Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Matthay · SciRah

Researcher profile · Semantic Scholar

K. Matthay

Share profile

K. Matthay — researcher profile on SciRah

h-index: 100
Works: 452
Citations: 36K

Most-cited papers

Advancing therapy for neuroblastoma
B. Qiu, K. Matthay
2022Nature Reviews Clinical Oncology365 citations
Semantic Scholar
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Julie R. Park, R. Bagatell, S. Cohn, A. D. Pearson +15 more
2017Journal of Clinical Oncology320 citations Open access
Semantic Scholar
Neuroblastoma: clinical and biological approach to risk stratification and treatment
V. Tolbert, K. Matthay
2018Cell and Tissue Research262 citations Open access
Semantic Scholar
Long-term follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-risk Neuroblastoma: Children’s Oncology Group Study ANBL0032
A. Yu, A. Gilman, M. F. Ozkaynak, A. Naranjo +15 more
2021Clinical Cancer Research158 citations Open access
Semantic Scholar
Association of MYCN Copy Number with Clinical Features, Tumor Biology, and Outcomes in Neuroblastoma: A Report from the Children’s Oncology Group
Kevin M. Campbell, J. Gastier-Foster, M. Mann, Arlene Naranjo +10 more
2017Cancer137 citations Open access
Semantic Scholar
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
K. Goldsmith, Julie R. Park, K. Kayser, J. Malvar +31 more
2023Nature Medicine136 citations Open access
Semantic Scholar
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.
S. DuBois, A. Marachelian, E. Fox, Rachel A. Kudgus +15 more
2016Journal of Clinical Oncology131 citations Open access
Semantic Scholar
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database.
D. Morgenstern, W. London, D. Stephens, S. Volchenboum +8 more
2016European Journal of Cancer86 citations
Semantic Scholar
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
J. Villablanca, S. Volchenboum, Hwangeui Cho, Min H. Kang +13 more
2016Pediatric Blood & Cancer85 citations Open access
Semantic Scholar
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials
R. Ladenstein, B. Lambert, U. Pötschger, M. Castellani +17 more
2017European Journal of Nuclear Medicine and Molecular Imaging84 citations Open access
Semantic Scholar
Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
S. Dubois, Y. Mossé, E. Fox, Rachel A. Kudgus +25 more
2018Clinical Cancer Research77 citations Open access
Semantic Scholar
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
P. Chévez-Barrios, R. Eagle, M. Krailo, Jin Piao +11 more
2019Journal of Clinical Oncology68 citations Open access
Semantic Scholar
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium
S. DuBois, M. Granger, S. Groshen, D. Tsao-Wei +22 more
2021Journal of Clinical Oncology65 citations Open access
Semantic Scholar
Neuroblastoma Patients’ KIR and KIR-ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children’s Oncology Group
A. Erbe, Wei Wang, L. Carmichael, KyungMann Kim +19 more
2017Clinical Cancer Research59 citations Open access
Semantic Scholar
Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis
A. Marachelian, J. Villablanca, C. Liu, Beifang Liu +18 more
2017Clinical Cancer Research49 citations
Semantic Scholar
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
Clare J. Twist, A. Naranjo, M. L. Schmidt, Sheena C. Tenney +9 more
2019Journal of Clinical Oncology47 citations Open access
Semantic Scholar
124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma
M. Aboian, Shih-Ying Huang, M. Hernandez-Pampaloni, R. Hawkins +6 more
2020Journal of Nuclear Medicine46 citations Open access
Semantic Scholar
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
P. D. de Alarcón, K. Matthay, W. London, A. Naranjo +6 more
2017The Lancet Child & Adolescent Health46 citations Open access
Semantic Scholar
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group
A. Desai, A. Gilman, M. Ozkaynak, A. Naranjo +16 more
2022Journal of Clinical Oncology38 citations Open access
Semantic Scholar
Association of image‐defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma
W. Temple, Kieuhoa T. Vo, K. Matthay, B. Balliu +5 more
2020Cancer Medicine36 citations Open access
Semantic Scholar
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children’s Oncology Group
S. Dubois, R. Mody, A. Naranjo, C. van Ryn +13 more
2017Pediatric Blood & Cancer35 citations Open access
Semantic Scholar
A Safety and Feasibility Trial of 131I-MIBG in Newly Diagnosed High-Risk Neuroblastoma: A Children’s Oncology Group (COG) Study
Brian D. Weiss, G. Yanik, A. Naranjo, Fan F. Zhang +16 more
2021Pediatric Blood & Cancer32 citations Open access
Semantic Scholar
Differences in Genomic Profiles and Outcomes between Thoracic and Adrenal Neuroblastoma.
D. Oldridge, B. Truong, Douglas H Russ, S. DuBois +5 more
2019Journal of the National Cancer Institute32 citations Open access
Semantic Scholar
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project
Kevin M. Campbell, Derek Shyr, R. Bagatell, M. Fischer +6 more
2019Pediatric Blood & Cancer31 citations Open access
Semantic Scholar
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial
N. Pinto, S. DuBois, A. Marachelian, Scott J. Diede +13 more
2018Pediatric Blood & Cancer31 citations Open access
Semantic Scholar
Neuroblastoma: clinical and biological approach to risk stratification and treatment
V. Tolbert, K. Matthay
2018Cell and Tissue Research31 citations Open access
Semantic Scholar
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.
Richard Li, Alexei L. Polishchuk, S. DuBois, R. Hawkins +10 more
2017International Journal of Radiation Oncology, Biology, Physics29 citations
Semantic Scholar
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children’s Oncology Group
Kieuhoa T. Vo, Jeremy V. Edwards, C. L. Epling, E. Sinclair +13 more
2016Clinical Cancer Research24 citations Open access
Semantic Scholar
Phase I trial of lorlatinib in patients with ALK-driven refractory or relapsed neuroblastoma: A New Approaches to Neuroblastoma Consortium study.
K. Goldsmith, K. Kayser, S. Groshen, M. Chioda +11 more
202023 citations
Semantic Scholar
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131I-metaiodobenzylguanidine
K. Huibregtse, Kieuhoa T. Vo, S. DuBois, S. Fetzko +7 more
2016European Journal of Cancer22 citations Open access
Semantic Scholar
Early Phase Clinical Trial Eligibility and Response Evaluation Criteria for Refractory, Relapsed or Progressive Neuroblastoma: A Consensus Statement from the National Cancer Institute-Clinical Trials Planning Meeting
Julie R. Park, J. Villablanca, B. Hero, B. Kushner +10 more
2022Cancer21 citations Open access
Semantic Scholar
Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with 131I-mIBG, a Targeted Radionuclide
David A. Edmondson, Erin E. Karski, A. Kohlgruber, Harsha Koneru +6 more
2016Radiation Research21 citations Open access
Semantic Scholar
Role of Extent of Prophylactic Regional Lymph Node Radiotherapy on Survival in High Risk Neuroblastoma: A Report from the COG A3973 Study
S. Braunstein, W. London, S. Kreissman, J. Villablanca +14 more
2019Pediatric Blood & Cancer20 citations Open access
Semantic Scholar
Technical Note: Simplified and practical pretherapy tumor dosimetry – A feasibility study for 131I-MIBG therapy of neuroblastoma using 124I-MIBG PET/CT
Youngho Seo, Y. Huh, Shih-Ying Huang, J. M. Hernandez-Pampaloni +4 more
2019Medical Physics (Lancaster)18 citations Open access
Semantic Scholar
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
Miller Huang, Wanqi Fang, Alvin Farrel, Lin-Wei Li +18 more
2024Cell Reports17 citations Open access
Semantic Scholar
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
M. Hogarty, David S. Ziegler, Andrea T. Franson, Yueh-Yun Chi +14 more
2024British Journal of Cancer17 citations Open access
Semantic Scholar
Risk factors for transplant-associated thrombotic microangiopathy following autologous hematopoietic cell transplantation in high-risk neuroblastoma
V. Tolbert, C. Dvorak, C. Golden, Madhav Vissa +4 more
2019Biology of Blood and Marrow Transplantation17 citations Open access
Semantic Scholar
Pattern and predictors of sites of relapse in neuroblastoma: a report from the International Neuroblastoma Risk Group (INRG) project
Kieuhoa T. Vo, S. DuBois, J. Neuhaus, S. Braunstein +5 more
2022Pediatric Blood & Cancer15 citations Open access
Semantic Scholar
Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma
J. Villablanca, Ling-Yun Ji, Adi Shapira-Lewinson, A. Marachelian +8 more
2018Pediatric Blood & Cancer14 citations Open access
Semantic Scholar
Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource‐limited countries
K. Matthay, Jennifer Hylton, Neela L. Penumarthy, M. Khattab +12 more
2022Pediatric Blood & Cancer13 citations
Semantic Scholar
Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives
Prerna Kumar, R. Gill, Andrew S. Phelps, Asmin Tulpule +2 more
2018Cureus13 citations Open access
Semantic Scholar
Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma
Kieuhoa T. Vo, K. Matthay, S. DuBois
2016Clinical Sarcoma Research13 citations Open access
Semantic Scholar
Physician Perspectives on Palliative Care for Children With Neuroblastoma: An International Context
E. M. Balkin, Daria L. Thompson, K. Colson, Catherine G. Lam +1 more
2016Pediatric Blood & Cancer12 citations
Semantic Scholar
Impact of Diagnostic and End-of-Induction Curie Scores with Tandem High-Dose Chemotherapy and Autologous Transplants for Metastatic High-Risk Neuroblastoma: A Report from the Children’s Oncology Group
K. Streby, M. Parisi, B. Shulkin, B. LaBarre +10 more
2023Pediatric Blood & Cancer11 citations Open access
Semantic Scholar
Interleukin 2 plus anti-GD2 immunotherapy: helpful or harmful?
K. Matthay
2018The Lancet Oncology11 citations
Semantic Scholar
Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma
Tu Dinh, B. Truong, K. Matthay, S. DuBois
2017Journal of pediatric hematology/oncology11 citations
Semantic Scholar
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Miriam I. Rosenberg, Erez Greenstein, Martin L. Buchkovich, Ayelet Peres +17 more
2021bioRxiv10 citations Open access
Semantic Scholar
Phase I Study of 131I-MIBG with Dinutuximab +/− Vorinostat for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
T. Cash, A. Marachelian, S. Dubois, Yueh-Yun Chi +25 more
2025Journal of Clinical Oncology8 citations
Semantic Scholar
Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.
Kieuhoa T. Vo, Jennifer Michlitsch, A. Shah, J. Reid +8 more
20208 citations
Semantic Scholar
An Intensive Induction Protocol for High Risk Neuroblastoma in Morocco
Z. Salman, M. El Kababri, L. Hessissen, M. Khattab +1 more
20168 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Julie R. Park×17
Invite
Julie R. Park — researcher profile on SciRah
S. DuBois×13
Invite
S. DuBois — researcher profile on SciRah
H. Shimada×12
Invite
H. Shimada — researcher profile on SciRah
Kieuhoa T. Vo×12
Invite
Kieuhoa T. Vo — researcher profile on SciRah

×12

Invite

A. Marachelian — researcher profile on SciRah

J. Villablanca×11

Invite

J. Villablanca — researcher profile on SciRah

Invite

A. Naranjo — researcher profile on SciRah

Invite

J. Maris — researcher profile on SciRah

R. Bagatell×10

Invite

R. Bagatell — researcher profile on SciRah

Invite

W. London — researcher profile on SciRah

Invite

S. Groshen — researcher profile on SciRah

F. Goodarzian×8

Invite

F. Goodarzian — researcher profile on SciRah